Skip to main content

Cytosorbents Corp

CTSO
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001175151

In the last 90 days, Cytosorbents Corp insiders filed 4 open-market purchases and 0 sales; 50 institutions reported holding it in 13F filings for Q2 2026, worth $6.04M in total; no superinvestor holds it.

Q3 2021 vs. Q2 2021

How the institutions holding Cytosorbents Corp changed between Q2 2021 and Q3 2021.

All holders in Q3 2021All holders in Q2 2021

13F holders of CTSO: Q2 2021 compared with Q3 2021
MeasureQ2 2021Q3 2021Change
Holders10296−6
Shares17.5M18.4M+841.8K (+4.8%)
Value$132.4M$149.2M+$16.8M (+12.7%)

New holders (9)

Institutions that held Cytosorbents Corp at the end of Q3 2021 but not at the end of Q2 2021.

Institutions new to CTSO in Q3 2021
InstitutionSharesValue% of portfolio
Soleus Capital Management, L.P.800,000$6.50M1.01%
Bank of Montreal117,966$1.01M0.00%
MetLife Investment Management15,424$125.2K0.00%
SG Americas Securities, LLC14,044$114.0K0.00%
Metropolitan Life Insurance Co11,670$94.8K0.00%
Group One Trading, L.P.1,654$13.0K0.00%
Cowen Prime Advisors LLC1,200$10.0K0.00%
Total Clarity Wealth Management, Inc.521$4.00K0.00%
First Horizon Advisors, Inc.456$3.00K0.00%

Sold out (15)

Institutions that held Cytosorbents Corp at the end of Q2 2021 and filed for Q3 2021 without it.